论文部分内容阅读
本文对57例子宫肉瘤的临床资料进行分析。结果显示子宫平滑肌肉瘤最为多见,占64.9%,子宫内膜间质肉瘤次之,占28.1%;恶性苗勒氏管混合瘤最少见,占7.0%。临床症状无特异性,以盆腔包块,子宫增大,月经过多、绝经后出血、宫口赘生物、阴道排液为主。转移途径多见血性转移.且多发生在2年内。治疗以手术为主,辅以化疗及放疗。2年存活率为52.1%.5年存活率为35.4%。治疗效果与病理类型关系不大,而与临床分期有关。临床分期越高.疗效越差,存活率越低。
This article analyzes the clinical data of 57 cases of uterine sarcoma. The results showed that the most common uterine leiomyosarcoma, accounting for 64.9%, followed by endometrial stromal sarcoma, accounting for 28.1%; Malignant Mullerian mixed tumor is the most common, accounting for 7.0%. No specific clinical symptoms, pelvic mass, uterine enlargement, menorrhagia, postmenopausal bleeding, cervix vegetation, mainly vaginal discharge. Metastasis more common hematogenous metastasis. And occurred in 2 years. Surgery-based treatment, supplemented by chemotherapy and radiotherapy. The 2-year survival rate was 52.1% and the 5-year survival rate was 35.4%. The effect of treatment is not related to the type of pathology, but related to clinical stage. The higher the clinical stage, the poorer the efficacy and the lower the survival rate.